4Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of moreintensivelowering of LDL cholesterol : a meta - analysis of data from 170000 participantsin 26 randomisedtrials [ J ]. Lancet, 2010,376 : 1670-1681.
5Reiner Z, Alberico L, Backer G D, et al. ESC/EAS Guidelines for the management of dyslipidaemias [ J ]. European Heart Journal, 2011, 32:1769 - 1818.
7Jones P H, Davidson M H, Stein E A, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastitin across doses ( STELLAR trial) [ J ]. Am J Cardiol, 2003, 92 : 152-160.
8Franssen R,Vergeer M, Stroes E S, et al. Combination statin -brate therapy : safety aspects [ J ]. Diabetes Obes Metab ,2009,11 : 89-94.
4European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011,32 : 1769-1818.
5World Health Organization.Multination monitoring of treads and determinants in cardiovascular disease (MONICA project) and manual of operation.Cardiovascular Disease Unit,Geneva,1993.
6Wilson Peter WF,Agostino RBD,Levy D,et al.Prediction of coronary heart disease using risk factor categories (Framingham),Circulation,1998,97:1837-1847.
7National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report.Circulation,2002,106:3143-3421.
8Leppala JM,Virtamo J,Fogelholm R,et al.Different risk factors for different stroke subtypes:association of blood pressure,cholesterol,and antioxidants.Stroke,1999,30:2535-2540.
9Zhang X,Patel A,Horibe H,et al.Cholesterol,coronary heart disease,and stroke in the Asia Pacific region.Int J Epidemiol,2003,32:563-572.
10Kuulasmaa K,Pedoe TH,Dobson A,et al.Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.Lancet,2000,355:675-687.
